Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2007
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312227 Autoimmune diseases; Alzheimer's disease; Parkinson's disease; bone disorders; liver disorders; rheumatic disease; amythrophiic lateral sclerosis
12/25/2007US7312226 1-Benzo[1.3]dioxol-5-yl methyl-3-[2-(6,7-dimethoxy-quinazolin-4ylamino)-pyrimidin-5yl]-thiourea (14); anticarcinogenic, antitumor, antdiabetic, antiproliferative agent
12/25/2007US7312225 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases
12/25/2007US7312224 Pyrimidine derivatives
12/25/2007US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/21/2007WO2007146981A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
12/21/2007WO2007146977A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007WO2007146869A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
12/21/2007WO2007146225A2 Heterocyclic aspartyl protease inhibitors
12/21/2007WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007WO2007125547A9 Novel process for statins and its pharmaceutically acceptable salts thereof
12/21/2007WO2007117607A3 Quinazolines for pdk1 inhibition
12/21/2007WO2006083916A3 Novel adenosine a3 receptor modulators
12/21/2007WO2005051366A3 Diaryl urea derivatives in the treatment of protein kinase dependent diseases
12/21/2007CA2655315A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007CA2655146A1 Benzamide derivatives and uses related thereto
12/21/2007CA2654244A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
12/21/2007CA2653777A1 2-anilino-4-(heterocyclic)amino-pyrimidines
12/21/2007CA2653650A1 Heterocyclic aspartyl protease inhibitors
12/21/2007CA2653039A1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
12/20/2007US20070293671 Process for the Preparation of Risperidone
12/20/2007US20070293667 Such as (7-chloro-2-styryl-quinazolin-4-yl)-(3-imidazol-1-yl-propyl)-amine; glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents
12/20/2007US20070293525 2-anilino-4-aminoalkyleneaminopyrimidines
12/20/2007US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade
12/20/2007US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293522 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293520 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293517 Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
12/20/2007US20070293491 Indazole compounds and methods for inhibition of cdc7
12/20/2007US20070293490 Quinazoline Derivatives
12/20/2007US20070293464 Substituted Pyrimidine Compositions and Methods of Use
12/20/2007US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer
12/19/2007EP1867645A1 Variolin derivatives and their use as antitumor agents
12/19/2007EP1866311A2 Novel compounds
12/19/2007EP1866290A1 Prokineticin 1 receptor antagonists
12/19/2007EP1866289A1 Pyrimidine carboxylic acid derivatives and use thereof
12/19/2007EP1865775A1 Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
12/19/2007EP1701946B1 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
12/19/2007EP1692115B1 Method for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils
12/19/2007EP1539713B1 Pyrimidine derivatives as modulators of chemokine receptor activity
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1470122B1 Rho-kinase inhibitors
12/19/2007EP1465875B1 Novel alkansulfonamides as endothelin antagonists
12/19/2007EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN101090883A Substituted hydroxyethylamines
12/19/2007CN101088991A Process of preparing (s)-2-(2-carbonyl-tetrahydropyrimidyl-1-(2H)-3-methyl butyric acid
12/18/2007US7309704 Piperidinyl- and pyrimidinyl-ureas: N-(1-acetyl-4-piperidinyl)-N-methyl-N'-(5-(3,5-difluorophenyl)-2-pyrimidinyl)urea; metabolic disorders, eating disorders, disorders associated with obesity: type II diabetes, insulin resistance, hyperlipidemia or hypertension.
12/13/2007WO2007140957A1 Sulfimides as protein kinase inhibitors
12/13/2007WO2007140847A1 Materials for organic electroluminescent devices
12/13/2007US20070287843 Methods and Intermediates for the Synthesis of Delta-9 Tetrahydrocannabinol
12/13/2007US20070287716 Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors
12/13/2007US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
12/13/2007US20070287703 Fused Pyrimidones Useful in the Treatment and the Prevention of Cancer
12/13/2007US20070287697 Cgrp Receptor Antagonists
12/13/2007US20070287677 Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof
12/13/2007US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections
12/13/2007DE102006027156A1 New sulfimide compounds are protein kinase inhibitors useful to treat e.g. cancer, Hodgkin's lymphoma, Kaposi's sarcoma, cardiovascular disease, Crohn's disease, endometriosis and hemangioma
12/13/2007CA2654318A1 Sulphimides as protein kinase inhibitors
12/12/2007EP1864977A1 Novel cyclic compound having pyrimidinylalkylthio group
12/12/2007EP1863805A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
12/12/2007EP1863773A1 Process for preparation of rosuvastatin
12/12/2007EP1863772A1 Amide derivatives as ppar activators
12/12/2007EP1644357B1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/12/2007EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
12/12/2007EP1268481B1 Kinase inhibitors as therapeutic agents
12/12/2007CN101087792A Synthetic process for preparing dual loop compound
12/12/2007CN101087780A Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs
12/12/2007CN101087768A Thrombopoietin activity modulating compounds and methods
12/12/2007CN101087759A Anthracene derivative and organic electroluminescent element using the same
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN100354268C Novel triazolo pyrimidine compounds
12/12/2007CN100354267C Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
12/11/2007US7307168 Process for the preparation of 3-{2-′4- (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyllethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido′1,2-methyl-4h-pyrido′,2-a!pyrimidin-4-one
12/11/2007US7307092 Compounds Capable of Activating Cholinergic Receptors
12/11/2007US7307065 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007139492A1 Hexahydropyrimidine, tetrahydro imidazole or octahydroazepan derivatives
12/06/2007WO2007139240A1 7-(3,4-dialkoxyphenyl)-pyrazolo[1,5-a]pyrimidine compounds, process for preparing thereof, and pharmaceutical composition for treating or preventing asthma, chronic obstructive pulmonary disease, arthritis, atopic dermatitis, tumor and degenerative brain diseases comprising the same
12/06/2007WO2007138994A1 Hsp90 inhibitor
12/06/2007WO2007138705A1 Tumor suppressor
12/06/2007WO2007138613A2 A process for synthesis of [6,7-bis-(2-methoxyethoxy)-quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride
12/06/2007WO2007138612A2 A process for synthesis of [6,7-bis-(2-methoxyethoxy)-quinazolin-4- yl]-(3-ethynylphenyl)amine hydrochloride
12/06/2007WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007WO2007137955A1 Piperidinyl pyrimidine derivatives
12/06/2007WO2007056221A3 Aminopyrimidines useful as kinase inhibitors
12/06/2007WO2007022366A8 Rosuvastatin calcium with a low salt by-product content
12/06/2007US20070282103 Process for the Preparation of Thiazolopyrimidines
12/06/2007US20070281956 Phenylpyrimidine amines as IgE inhibitors
12/06/2007US20070281955 e.g. 3-{5-[2-({(3R)-1-[(4-chlorophenyl)sulfonyl]piperidin-3-yl}amino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl carbamate; antiproliferative, anticarcinogenic agent; cell proliferative disorders
12/06/2007US20070281954 Cyclohexyl-1,4-diamine compounds
12/06/2007US20070281953 Substituted Dihydroquinazolines II
12/06/2007US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
12/06/2007US20070281948 Substituted 2-pyridone derivatives, method for their preparation and their use as medicament
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 427